SCHEMBL3635111

SCHEMBL3635111

CC(C)(C)OC(=O)N(Nc1ncc(N)cn1)C1CCNC1

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 16/20 0.35
SLC6A2 P23975 15/20 0.35
SLC6A3 Q01959 11/20 0.35
CYP2D6 P10635 4/20 0.35
KCNH2 Q12809 4/20 0.32
SYK P43405 2/20 0.32
MAPK3 P27361 1/20 0.32
MAPK1 P28482 1/20 0.32
AURKB Q96GD4 1/20 0.32
CHRM3 P20309 1/20 0.32
PTK2 Q05397 1/20 0.31
CDK1 P06493 1/20 0.31
CDK4 P11802 1/20 0.31
CCND1 P24385 1/20 0.31
CDK2 P24941 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3635108 1.00 SLC6A4 (0.35) SLC6A4SLC6A2SLC6A3CYP2D6KCNH2
SCHEMBL529996 0.81 SLC6A4 (0.36) SLC6A4SLC6A2SLC6A3CYP2D6KCNH2
SCHEMBL14497286 0.73 SLC6A4 (0.36) SLC6A4SLC6A2SLC6A3CYP2D6KCNH2
SCHEMBL28329578 0.71 SLC6A4 (0.39) SLC6A4SLC6A2SLC6A3CYP2D6KCNH2
SCHEMBL18142028 0.70 SLC6A4 (0.35) SLC6A4SLC6A2SLC6A3CYP2D6KCNH2
SCHEMBL31250397 0.70 SLC6A4 (0.38) SLC6A4SLC6A2SLC6A3CYP2D6KCNH2
SCHEMBL28036679 0.70 SLC6A4 (0.38) SLC6A4SLC6A2SLC6A3CYP2D6KCNH2
SCHEMBL529544 0.70 RPLP1 (0.36) KCNH2
SCHEMBL529417 0.70 RPLP1 (0.36) KCNH2
SCHEMBL4439873 0.68 SLC6A4 (0.36) SLC6A4SLC6A2SLC6A3CYP2D6KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155687-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS Via Pharmaceuticals, Inc. (US) 2010-02-24 EP disclosed
WO-2008141976-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS VIA PHARMACEUTICALS, INC. (US) 2008-11-27 WO disclosed